Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8780625 | Gynecologic Oncology | 2018 | 8 Pages |
Abstract
In order to avoid exposing patients unnecessarily to chemotherapy, close surveillance of women with pathological diagnosis of nonmetastatic GCC seems to be a safe practice, particularly for those who have a normal hCG at the time of diagnosis. If confirmed by other studies, the FIGO guidelines may need to be revised.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Antonio Braga, Vanessa Campos, Jorge Rezende Filho, Lawrence H. Lin, Sue Yazaki Sun, Christiani Bisinoto de Souza, Rita de Cássia Alves Ferreira da Silva, Elaine Azevedo Soares Leal, Eduardo Silveira, Izildinha Maestá, José Mauro Madi, Elza H. Uberti,